Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory
1. Roche has launched one of the largest artificial intelligence infrastructures in the pharmaceutical industry, powered by over 3,500 NVIDIA ...
Tag: precision medicine
![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-350x250.png)
2MM: AI Roundup – Roche and NVIDIA’s AI drug discovery factory and surgical robotics foundation model, Amazon’s nationwide health AI expansion, and Brown’s AI therapy ethics warning [March 2026]
Roche and NVIDIA deploy the pharmaceutical industry's largest AI factory A major leap in computational drug development has emerged with ...
Pfizer’s Talzenna combo significantly delays prostate cancer progression
1. The combination of talazoparib and enzalutamide demonstrated a statistically significant improvement in radiographic progression-free survival for metastatic hormone-sensitive prostate ...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]
Pfizer’s Talzenna combo significantly delays progression in frontline prostate cancer Topline results from the Phase 3 TALAPRO-3 study indicate that ...
Merck and Mayo Clinic launch AI-driven precision medicine lab
1. Merck and Mayo Clinic have launched a strategic collaboration to integrate multimodal clinical data with AI to accelerate drug ...
2 Minute Medicine: Pharma Roundup – Merck and Mayo Clinic’s AI precision medicine lab, Novartis’ remibrutinib hits Phase III hive endpoint, FDA grants priority review for iberdomide in myeloma, oral infigratinib boosts growth velocity in achondroplasia, and shingles vaccine/sildenafil linked to lower Alzheimer’s risk [February 2026]
Merck and Mayo Clinic launch AI-driven precision medicine partnership Merck and Mayo Clinic have officially kicked off a landmark R&D ...
Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
1. A new AI workflow utilizing large language models can predict with 99% accuracy which ulcerative colitis patients will remain ...
Biomarkers distinguish pediatric musculoskeletal infections from similar conditions
1. In a prospective cohort study, white blood cell (WBC) count, absolute neutrophil count (ANC), C-reactive protein (CRP), erythrocyte sedimentation rate ...
